The company said it has decided to price its version of Risdiplam product at Rs 15,900, and further added that it intends to ...

The stock rose 2.95 per cent to hit a high of Rs 789. It was last seen trading 1.44 per cent up at Rs 777.45. At this price, ...

Nifty Pharma has fallen by 12.8 per cent so far this year, with Natco Pharma and Granules India leading the plunge ...

Natco Pharma updates on Risdiplam launch in India, Delhi High Court denies Roche's injunction plea, pricing set at ₹15,900.

Telangana: Natco Pharma has announced the superannuation of Dr Ramesh Dandala, Executive Vice President - Technology Transfer ...

Natco Pharma has announced the supperannuation of Tummala Venkata Rao, Vice President - Production of the Company."With ...

Other names on the Nifty Pharma index that has a significant upside potential include Aurobindo Pharma and Ajanta Pharma, both of which have an upside potential of 23%.

2. NATCO PHARMA COLOMBIA SAS in Columbia which was approved by the Board of Directors at their meeting held on 29th May, 2023. 3. NATCO PHARMA UK LIMITED in United Kingdom, which was approved by ...

Natco Pharma plans to launch generic Risdiplam pending Delhi High Court decision, offering discounts to patients.